{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:51Z","timestamp":1786116651882,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05333-8","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:35:04Z","timestamp":1786016104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FIB-4 is associated with Gleason grade group upgrading after radical prostatectomy: a comparison of inflammatory and AST\/ALT-based indices in active surveillance-eligible men"],"prefix":"10.1007","author":[{"given":"Osman","family":"K\u00f6se","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Tekinaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcrsad","family":"D\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enis Mert","family":"Yorulmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"Candemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacit Nuri","family":"G\u00f6rgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u011fit","family":"Ak\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"5","key":"5333_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","volume":"61","author":"JI Epstein","year":"2012","unstructured":"Epstein JI, Feng Z, Trock BJ, Pierorazio PM (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61(5):1019\u20131024","journal-title":"Eur Urol"},{"issue":"2","key":"5333_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajur.2023.01.002","volume":"11","author":"S Salciccia","year":"2024","unstructured":"Salciccia S, Frisenda M, Bevilacqua G et al (2024) Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: a meta-analysis and systematic review. Asian J Urol 11(2):191\u2013207","journal-title":"Asian J Urol"},{"issue":"1","key":"5333_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03924-y","volume":"21","author":"L Meng","year":"2023","unstructured":"Meng L, Yang Y, Hu X, Zhang R, Li X (2023) Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med 21(1):79","journal-title":"J Transl Med"},{"key":"5333_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.70059","author":"S Yenig\u00fcrb\u00fcz","year":"2025","unstructured":"Yenig\u00fcrb\u00fcz S, Ediz C, Akan S, Kati B, Vural Y, Alcin A, Yilmaz O (2025) Significance of inflammation markers to predict curative treatment for prostate cancer patients on active surveillance. J Clin Lab Anal. https:\/\/doi.org\/10.1002\/jcla.70059","journal-title":"J Clin Lab Anal."},{"issue":"9","key":"5333_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s11255-017-1618-7","volume":"49","author":"H Wang","year":"2017","unstructured":"Wang H, Fang K, Zhang J et al (2017) The significance of De Ritis (aspartate transaminase\/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients. Int Urol Nephrol 49(9):1391\u20131398. https:\/\/doi.org\/10.1007\/s11255-017-1618-7","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"5333_CR6","first-page":"48","volume":"14","author":"CT Gezmi\u015f","year":"2024","unstructured":"Gezmi\u015f CT, \u00d6zkan A, Kalkanl\u0131 A, \u00c7ilesiz NC, \u00d6zdemir E, Hazar A\u0130 (2024) Investigation of the predictive value of De Ritis ratio and inflammatory markers in prostate cancer patients suitable for active surveillance. J Acad Res Med. 14(2):48\u201353","journal-title":"J Acad Res Med."},{"issue":"3191","key":"5333_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123(3191):309\u2013314","journal-title":"Science"},{"issue":"6","key":"5333_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43(6):1317\u20131325","journal-title":"Hepatology"},{"issue":"1","key":"5333_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010066","volume":"15","author":"Y Kamada","year":"2023","unstructured":"Kamada Y, Munekage K, Nakahara T et al (2023) The FIB-4 index predicts the development of liver-related events, extrahepatic cancers, and coronary vascular disease in patients with NAFLD. Nutrients 15(1):66","journal-title":"Nutrients"},{"issue":"10","key":"5333_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102301","volume":"13","author":"M Kim","year":"2021","unstructured":"Kim M, Lee Y, Yoon JS, Lee M, Kye SS, Kim SW, Cho Y (2021) The FIB-4 index is a useful predictor for the development of hepatocellular carcinoma in patients with coexisting nonalcoholic fatty liver disease and chronic hepatitis B. Cancers 13(10):2301","journal-title":"Cancers"},{"issue":"1","key":"5333_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000598","volume":"4","author":"Y Sato","year":"2017","unstructured":"Sato Y, Yoshihisa A, Kanno Y et al (2017) Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598. https:\/\/doi.org\/10.1136\/openhrt-2017-000598","journal-title":"Open Heart"},{"issue":"9","key":"5333_CR12","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-020-08828-5","volume":"27","author":"T Akiyama","year":"2020","unstructured":"Akiyama T, Miyamoto Y, Imai K et al (2020) Fibrosis-4 index, a noninvasive fibrosis marker, predicts survival outcomes after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 27(9):3534\u20133541. https:\/\/doi.org\/10.1245\/s10434-020-08828-5","journal-title":"Ann Surg Oncol"},{"key":"5333_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655343","volume":"11","author":"K Xu","year":"2021","unstructured":"Xu K, Shi M, Zhang W et al (2021) Preoperative Fibrosis-4 (FIB-4) evaluation may be helpful to evaluate prognosis of gastric cancer patients undergoing operation: a retrospective study. Front Oncol 11:655343","journal-title":"Front Oncol"},{"key":"5333_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86212-7","volume":"15","author":"Y Ishizuya","year":"2025","unstructured":"Ishizuya Y, Kawashima A, Horibe Y et al (2025) FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma. Sci Rep 15:4640. https:\/\/doi.org\/10.1038\/s41598-025-86212-7","journal-title":"Sci Rep"},{"issue":"8","key":"5333_CR15","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"GJLH van Leenders","year":"2020","unstructured":"van Leenders GJLH, van der Kwast TH, Grignon DJ et al (2020) The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol 44(8):e87\u2013e99","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"5333_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163","journal-title":"Eur Urol"},{"issue":"2","key":"5333_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11255-011-0020-0","volume":"44","author":"P Sooriakumaran","year":"2012","unstructured":"Sooriakumaran P, Srivastava A, Christos P, Grover S, Shevchuk M, Tewari A (2012) Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer. Int Urol Nephrol 44(2):459\u2013470. https:\/\/doi.org\/10.1007\/s11255-011-0020-0","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"5333_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11255-025-04641-9","volume":"58","author":"TH Hwang","year":"2026","unstructured":"Hwang TH, Yu YD, Choi KH, Lee SR, Hong YK, Park DS, Kim TH (2026) The volume of Gleason grade group 1 prostate cancer at biopsy predicts unfavorable pathology but not upgrading after radical prostatectomy. Int Urol Nephrol 58(1):91\u201396. https:\/\/doi.org\/10.1007\/s11255-025-04641-9","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"5333_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4111\/kju.2015.56.9.624","volume":"56","author":"BS Jin","year":"2015","unstructured":"Jin BS, Kang SH, Kim DY et al (2015) Pathological upgrading in prostate cancer patients eligible for active surveillance: does prostate-specific antigen density matter? Korean J Urol 56(9):624\u2013629","journal-title":"Korean J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05333-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:35:05Z","timestamp":1786016105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05333-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":19,"alternative-id":["5333"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05333-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the \u0130zmir K\u00e2tip \u00c7elebi University Health Research Ethics Committee (approval no. 0172; approval date: April 8, 2025) and was conducted in accordance with the principles of the Declaration of Helsinki. The institutional ethics committee waived the requirement for informed consent due to the retrospective design of the study and the use of anonymized patient data.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}